Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Hum Mutat ; 19(2): 186-7, 2002 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-11793485

RESUMO

Wiskott-Aldrich syndrome (WAS), is an X-linked immunodeficiency disease caused by mutations of the WAS protein (WASP) gene, characterized by thrombocytopenia, eczema and recurrent infections. X-linked thrombocytopenia (XLT) is a milder form with only platelet abnormalities. Cumulative mutation data have revealed that WASP genotypes are highly variable among WAS patients. By SSCP analysis, we determined the location of the mutation in 23 WAS patients from 17 unrelated families with variable clinical phenotypes. Direct sequence analysis of genomic DNA showed 9 novel mutations (Q52H, G70W, 393del7, Ex 7 Ex11del, IVS 8+1G-->C, 925delG, 959ins38, 1380del8, and IVS 2+2T-->C) and 8 known mutations distributed throughout the WAS gene. This is the first report of WAS gene mutations from a Latin American country.


Assuntos
Mutação/genética , Proteínas/genética , Síndrome de Wiskott-Aldrich/genética , Argentina/epidemiologia , Análise Mutacional de DNA , Éxons/genética , Testes Genéticos , Genótipo , Humanos , Íntrons/genética , Masculino , Fenótipo , Polimorfismo Conformacional de Fita Simples , Síndrome de Wiskott-Aldrich/epidemiologia , Síndrome de Wiskott-Aldrich/fisiopatologia , Proteína da Síndrome de Wiskott-Aldrich
2.
J Pediatr ; 97(1): 72-8, 1980 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-7381651

RESUMO

Information was collected on 301 cases of the Wiskott-Aldrich syndrome in the United States and Canada Examination of available medical records, death certificates and published case reports on these patients showed that they came from a wide geographic area and many diverse ethnic and racial groups. No significant difference was found in the incidence of cases born between 1947 and 1976; the overall rate was 4.0 per million live male births in the United States. Median survival has increased with time from eight months for patients born before 1935 to 6.5 years for those born after 1964. Seventy-six of the 301 patients (25%) were still alive at last follow-up and ranged in age from 1 to 36 years with a median of 10 years. Causes of death were primarily limited to infections or bleeding, but malignancy represented a significant problem. Twelve percent of the group (36 of 301) developed malignancy, the predominant types being lymphorecticular tumors (23 of 36) and leukemia (7 of 36). The overall relative risk for malignancy was found to be greater than 100 times that of the general population and was found to increase with increasing age.


Assuntos
Síndrome de Wiskott-Aldrich/epidemiologia , Adolescente , Adulto , Canadá , Criança , Pré-Escolar , Feminino , Humanos , Lactente , Recém-Nascido , Masculino , Neoplasias/complicações , Risco , Estados Unidos , Síndrome de Wiskott-Aldrich/complicações , Síndrome de Wiskott-Aldrich/mortalidade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA